tiprankstipranks
Trending News
More News >
Pharmarise Holdings Corp. (JP:2796)
:2796
Japanese Market
Advertisement

Pharmarise Holdings Corp. (2796) Income Statement

Compare
0 Followers

Pharmarise Holdings Corp. Income Statement

Last quarter (Q3 2024), Pharmarise Holdings Corp.'s total revenue was ¥16.04B, an increase of 16.82% from the same quarter last year. In Q3, Pharmarise Holdings Corp.'s net income was ¥-158.00M. See Pharmarise Holdings Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 63.51B¥ 54.47B¥ 52.03B¥ 51.61B¥ 52.32B
Gross Profit
¥ 8.96B¥ 8.45B¥ 8.13B¥ 8.12B¥ 8.07B
Operating Expenses
¥ 8.67B¥ 7.53B¥ 6.70B¥ 6.60B¥ 6.82B
Depreciation and Amortization
¥ 1.49B¥ 1.17B¥ 1.22B¥ 1.31B¥ 1.34B
EBITDA
¥ 1.68B¥ 1.38B¥ 2.33B¥ 2.69B¥ 2.62B
Operating Income
¥ 293.00M¥ 916.00M¥ 1.44B¥ 1.52B¥ 1.25B
Other Income/Expenses
¥ -285.00M¥ -773.00M¥ -389.00M¥ -199.00M¥ -44.00M
Pretax Income
¥ 8.00M¥ 143.00M¥ 1.05B¥ 1.32B¥ 1.20B
Net Income
¥ -367.00M¥ -351.00M¥ 333.00M¥ 447.00M¥ 426.00M
Per Share Metrics
Basic EPS
¥ -32.42¥ -33.35¥ 35.42¥ 47.90¥ 45.78
Diluted EPS
¥ -32.42¥ -33.35¥ 26.86¥ 36.22¥ 34.59
Weighted Average Shares Outstanding
11.32M 10.52M 9.40M 9.33M 9.31M
Weighted Average Shares Outstanding (Diluted)
11.32M 10.52M 12.47M 12.40M 12.37M
Currency in JPY

Pharmarise Holdings Corp. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis